91 related articles for article (PubMed ID: 7941780)
41. Selectivity and potency of opioid peptides in regulating human chorionic gonadotropin release from term trophoblast tissue.
Cemerikic B; Schabbing R; Ahmed MS
Peptides; 1992; 13(5):897-903. PubMed ID: 1362265
[TBL] [Abstract][Full Text] [Related]
42. Multidimensional behavioral analyses show dynorphin A-(1-13) modulation of methamphetamine-induced behaviors in mice.
Ukai M; Toyoshi T; Kameyama T
Eur J Pharmacol; 1992 Nov; 222(1):7-12. PubMed ID: 1361442
[TBL] [Abstract][Full Text] [Related]
43. Opioids in the nucleus of the solitary tract are involved in feeding in the rat.
Kotz CM; Billington CJ; Levine AS
Am J Physiol; 1997 Apr; 272(4 Pt 2):R1028-32. PubMed ID: 9139997
[TBL] [Abstract][Full Text] [Related]
44. Effect of omega-conotoxin and verapamil on antinociceptive, behavioural and thermoregulatory responses to opioids in the rat.
Spampinato S; Speroni E; Govoni P; Pistacchio E; Romagnoli C; Murari G; Ferri S
Eur J Pharmacol; 1994 Mar; 254(3):229-38. PubMed ID: 8013557
[TBL] [Abstract][Full Text] [Related]
45. Stimulation of delta1- and delta2-opioid receptors produces amnesia in mice.
Ukai M; Takada A; Sasaki Y; Kameyama T
Eur J Pharmacol; 1997 Oct; 338(1):1-6. PubMed ID: 9407996
[TBL] [Abstract][Full Text] [Related]
46. Mu and delta opioid ligands inhibit reflex contractions of the urinary bladder in the rat by different central mechanisms.
Dray A; Nunan L
Neuropharmacology; 1987 Jul; 26(7A):753-9. PubMed ID: 3627383
[TBL] [Abstract][Full Text] [Related]
47. Behavioral effects of opioid peptide agonists DAMGO, DPDPE, and DAKLI on locomotor activities.
Meyer ME; Meyer ME
Pharmacol Biochem Behav; 1993 Jun; 45(2):315-20. PubMed ID: 8392203
[TBL] [Abstract][Full Text] [Related]
48. Effects of the kappa-opioid dynorphin A(1-13) on learning and memory in mice.
Ukai M; Itoh J; Kobayashi T; Shinkai N; Kameyama T
Behav Brain Res; 1997 Feb; 83(1-2):169-72. PubMed ID: 9062678
[TBL] [Abstract][Full Text] [Related]
49. Systemic administration of dynorphin A(1-13) markedly inhibits different behavioural responses induced by cocaine in the mouse.
Ukai M; Kamiya T; Toyoshi T; Kameyama T
Neuropharmacology; 1992 Sep; 31(9):843-9. PubMed ID: 1359442
[TBL] [Abstract][Full Text] [Related]
50. The difference in stress-induced analgesia in C57BL/6 and DBA/2 mice: a search for biochemical correlates.
Przewłocka B; Vetulani J; Lasoń W; Dziedzicka M; Silberring J; Castellano C; Przewłocki R
Pol J Pharmacol Pharm; 1988; 40(5):497-506. PubMed ID: 2908136
[TBL] [Abstract][Full Text] [Related]
51. The action of a synthetic derivative of Met5-enkephalin-Arg6-Phe7 on behavioral and endocrine responses.
Csabafi K; Jászberényi M; Bagosi Z; Tóth G; Wollemann M; Telegdy G
Peptides; 2011 Aug; 32(8):1656-60. PubMed ID: 21722680
[TBL] [Abstract][Full Text] [Related]
52. Dihydropyridino-sensitive calcium channels in opioid-induced thermic and behavioral effects.
Cavicchini E; Spampinato S; Speroni E; Coletti B; Murari G; Romagnoli C; Sotgiu R; Ferri S
Acta Physiol Hung; 1990; 75 Suppl():55-6. PubMed ID: 1973573
[No Abstract] [Full Text] [Related]
53. Opioid and non-opioid behavioral actions of dynorphin A and the dynorphin analogue DAKLI.
Trujillo KA; Akil H
NIDA Res Monogr; 1990; 105():397-8. PubMed ID: 1678871
[No Abstract] [Full Text] [Related]
54. Opioid inhibition of nicotine-induced 45Ca2(+)-uptake into cultured bovine adrenal medullary cells.
Bunn SJ; Dunkley PR
Biochem Pharmacol; 1991 Mar; 41(5):715-22. PubMed ID: 1671816
[TBL] [Abstract][Full Text] [Related]
55. [An experimental study of the pharmacological activity of opiate receptor ligands on models of adrenaline-induced arrhythmias].
Lishmanov IuB; Maslov LN; Ugdyzhekova DS
Eksp Klin Farmakol; 1995; 58(4):26-8. PubMed ID: 7580747
[TBL] [Abstract][Full Text] [Related]
56. antinociceptive properties of [D-Ala2, NMPhe4, Gly-ol]-enkephalin (DAGO) in tests of acute and tonic pain in mice.
Mulvaney SA; Sheldon RJ; Cowan A; Porreca F
Proc West Pharmacol Soc; 1988; 31():285-6. PubMed ID: 3211917
[No Abstract] [Full Text] [Related]
57. Effects of Tyr-D-Arg-Phe-beta-Ala-NH2, a novel dermorphin analog, on elevated plus-maze learning and spontaneous alternation performance in mice.
Ukai M; Monma J; Shinkai N; Sasaki Y; Kameyama T
Gen Pharmacol; 1997 Sep; 29(3):453-6. PubMed ID: 9378255
[TBL] [Abstract][Full Text] [Related]
58. Sensitization to the behavioral effects of cocaine: modulation by dynorphin and kappa-opioid receptor agonists.
Shippenberg TS; Rea W
Pharmacol Biochem Behav; 1997 Jul; 57(3):449-55. PubMed ID: 9218269
[TBL] [Abstract][Full Text] [Related]
59. Dynorphin A-(1-13) markedly improves scopolamine-induced impairment of spontaneous alternation performance in mice.
Itoh J; Ukai M; Kameyama T
Eur J Pharmacol; 1993 Jun; 236(3):341-5. PubMed ID: 8102969
[TBL] [Abstract][Full Text] [Related]
60. Effects of intraventricular beta-endorphin and D-ALA2-methionine-enkephalinamide on behaviour, spectrum power of electrocortical activity and body temperature in chicks.
Nisticõ G; Rotiroti D; Naccari F; De Sarro GB; Marmo E
Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):295-308. PubMed ID: 7394325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
